Robert Steinbrook

Learn More
545 the long term and other major risk factors, such as hypertension, cigarette smoking, obesity, and elevated levels of cholesterol or blood lipids. Although physicians know how to treat diabetes in individual patients, overall progress against the epidemic requires widespread improvement in glycemic control, as underscored by the recent finding that(More)
PERSPECTIVE 1091 getting an edge — use of stimulants and antidepressants in college S hould physicians sell their expertise and knowledge about clinical research to Wall Street? In recent months, financial relationships between some physicians and the investment industry have come under scrutiny. 1-3 Physicians have been paid to provide investors with(More)
116 not approved nesiritide and awaits the results of a trial involving 1900 patients before it will even consider doing so. 5 In my view, nesiritide has not yet met the minimal criteria for safety and efficacy. Until a trial definitively proves that this drug reduces the risk of death or repeated hospitalization for heart failure, there will be questions(More)
A series of articles in the New England Journal of Medicine has questioned whether the conflict of interest movement has gone too far in its campaign to stop the drug industry influencing the medical profession. Here, three former senior NEJM editors respond with dismay 1779 A seriously flawed and inflammatory attack on conflict of interest policies and(More)
  • 1